6
Participants
Start Date
January 31, 2010
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
Bortezomib (Velcade)
"Bortezomib will be administered as a 3-5 second bolus IV injection at the dose of 0.7 mg/m2 on days 1, 4, 8, and 11 q. 21 days times three cycles.~Patients will undergo three 21-day cycles."
University of Utah, Salt Lake City
Collaborators (1)
Millennium Pharmaceuticals, Inc.
INDUSTRY
University of Arkansas
OTHER